Aridis Pharmaceuticals Inc. (ARDS) Financials

ARDS Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 6.5 million 30.1 million
2023-06-30 6.5 million 21.4 million
2023-03-31 14.7 million 38.9 million
2022-12-31 14.7 million 38.9 million

ARDS Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -983000 200000
2023-06-30 -4.3 million 210000
2023-03-31 -8.6 million 318000
2022-12-31 -8.6 million 318000

ARDS Net Income

No data available :(

ARDS Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 35000 - 1.4 million
2023-06-30 19000 - 1.6 million
2023-03-31 4.9 million - 1.7 million
2022-12-31 - - 1.8 million

ARDS Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 37.4 million
2023-06-30 36.6 million
2023-03-31 22.0 million
2022-12-31 27.0 million

ARDS Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 - 175000 1.1 million -
2023-06-30 - 4.7 million 1.3 million -
2023-03-31 49000 7.0 million 1.6 million -
2022-12-31 49000 7.0 million 1.6 million -

ARDS Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 417000 -
2023-06-30 19.6 million -
2023-03-31 - -
2022-12-31 - -

ARDS

Price: $0.06

52 week price:
0.05
0.54

Earnings Per Share: -0.16 USD

P/E Ratio: -0.45

Exchange: PNK

Sector: Healthcare

Industry: Biotechnology

Volume: 543871

Market Capitalization: 3.2 million

Links: